Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-02
DOI
10.1007/s00228-019-02786-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
- (2019) Chandrasekaran Padmapriyadarsini et al. BMJ Open
- Metformin as a host-directed therapeutic in tuberculosis: Is there a promise?
- (2019) Wing Wai Yew et al. TUBERCULOSIS
- The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
- (2018) Sheng-Wei Pan et al. CHEST
- Diabetes is associated with increased prevalence of latent tuberculosis infection: Findings from the National Health and Nutrition Examination Survey, 2011–2012
- (2018) Marissa M. Barron et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up
- (2018) Y. Ma et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
- (2018) Simon Tiberi et al. LANCET INFECTIOUS DISEASES
- Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes
- (2018) Shang-Yi Lin et al. RESPIROLOGY
- The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus
- (2018) Ye-Jin Lee et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
- (2018) Mohammad H. Al-Shaer et al. BMC INFECTIOUS DISEASES
- Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
- (2018) Nathella P. Kumar et al. BMC INFECTIOUS DISEASES
- Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria
- (2018) Ming-Chia Lee et al. PLoS One
- Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients
- (2018) Chin-Hsiao Tseng Journal of Clinical Medicine
- Reduced prevalence of latent TB infection in diabetes patients using metformin and statins
- (2018) Matthew J Magee et al. EUROPEAN RESPIRATORY JOURNAL
- Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity
- (2018) Nathella P. Kumar et al. IMMUNOLOGY
- Influence of diabetes mellitus on immunity to human tuberculosis
- (2017) Pavan Kumar Nathella et al. IMMUNOLOGY
- Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus
- (2016) R. L. Hensel et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Glycemic Control and the Risk of Tuberculosis: A Cohort Study
- (2016) Pin-Hui Lee et al. PLOS MEDICINE
- Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis
- (2016) Argita D. Salindri et al. Open Forum Infectious Diseases
- Diabetes mellitus and tuberculosis: programmatic management issues
- (2015) A. D. Harries et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
- (2015) Rohit Vashisht et al. Journal of Translational Medicine
- Latent Tuberculosis in Patients with Diabetes Mellitus: Prevalence, Progression and Public Health Implications
- (2014) M. Leow et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Metformin as adjunct antituberculosis therapy
- (2014) A. Singhal et al. Science Translational Medicine
- Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
- (2013) Suraj P. Parihar et al. JOURNAL OF INFECTIOUS DISEASES
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes
- (2012) María Eugenia Jiménez-Corona et al. THORAX
- The impact of diabetes on tuberculosis treatment outcomes: A systematic review
- (2011) Meghan A Baker et al. BMC Medicine
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Tuberculosis and diabetes mellitus: convergence of two epidemics
- (2009) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood Cells
- (2008) Blanca I. Restrepo et al. CLINICAL INFECTIOUS DISEASES
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies
- (2008) Christie Y Jeon et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started